Over-the-Counter (OTC) Drugs Market Research Report, Growth & Forecast

Publications found: 387
Sort by:

2026-2031 Global OTC Anti-Infective Products Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region

US$ 3,150.00

HNY Research projects that the OTC Anti-Infective Products market size will grow from 14429.22 Million USD in 2025 to 18288.6 Million USD by 2031, at an estimated CAGR of 4.03%. The base year consider...

January 2026 148 pages

Nicotine Replacement Therapy Market - 2024-2032

US$ 3,400.00

Nicotine Replacement Therapy Market reached US$ 51.91 billion in 2024 and is expected to reach US$ 159.70 billion by 2032, growing with a CAGR of 14.40% during the forecast period 2026-2032. The Nicot...

January 2026 54 pages

Global Over the Counter (OTC) & Diet Supplementary Market 2026 by Company, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

... the Report: This report focuses on the Over the Counter (OTC) & Diet Supplementary in global market, especially in North America, Europe ... Chapters to deeply display the global Over the Counter (OTC) & Diet Supplementary market. Chapter 1, to describe Over the Counter (OTC) & Diet Supplementary Introduction, ...

January 2026 142 pages

The 2027-2032 World Outlook for OTC Drugs

US$ 1,195.00

This study covers the world outlook for OTC drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...

January 2026 288 pages

The 2027-2032 World Outlook for Over the Counter Drugs

US$ 1,195.00

This study covers the world outlook for over the counter drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....

January 2026 288 pages

Global Over the Counter (OTC) & Diet Supplementary Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Over the Counter (OTC) & Diet Supplementary market size is expected to reach $ 345710 million by 2032, rising at a market growth of 7.7% CAGR during the forecast period (2026-2032). The OTC...

January 2026 155 pages

Botulinum Toxin In Urology Market Outlook 2026-2034: Market Share, and Growth Analysis By Application (Overactive Bladder, Neurogenic Detrusor Overactivity), By End-User (Hospitals, Urology Clinics)

US$ 3,950.00

The Botulinum Toxin In Urology Market is valued at USD 1.02 billion in 2025 and is projected to grow at a CAGR of 5.7% to reach USD 1.73 billion by 2034. Botulinum Toxin In Urology Market Botulinum to...

November 2025 160 pages

Cushing Syndrome Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Glucocorticoid Receptor Antagonists, Pituitary-Directed Drugs, Steroidogenesis Inhibitors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

US$ 3,950.00

The Cushing Syndrome Market is valued at USD 0.1 billion in 2025 and is projected to grow at a CAGR of 24.9% to reach USD 1.29 billion by 2034. Cushing Syndrome Market Cushing syndrome (CS) is a rare...

November 2025 160 pages

Drugs for Malaria Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class (Aryl amino alcohol compounds, Antifolate compounds, Artemisinin compounds, Others) By Malaria Type (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Malariae, Plasmodium Ovale) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)

US$ 3,950.00

The Drugs for Malaria Market is valued at USD 1.11 billion in 2025 and is projected to grow at a CAGR of 4.9% to reach USD 1.74 billion by 2034. Drugs for Malaria Market The Drugs for Malaria market e...

November 2025 160 pages

Endocrinology Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis By Therapy Area (Adrenal Insufficiency, Diabetes, Thyroid Hormone Disorder, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

US$ 3,950.00

The Endocrinology Drugs Market is valued at USD 51.94 billion in 2025 and is projected to grow at a CAGR of 7.3% to reach USD 102.8 billion by 2034. Endocrinology Drugs Market The Endocrinology Drugs...

November 2025 160 pages

Pancrelipase Market Outlook 2026-2034: Market Share, and Growth Analysis By Age Group (Children, Adults, Geriatrics), By Application (Chronic Pancreatitis, Cystic Fibrosis, Others), By Distribution Channel

US$ 3,950.00

The Pancrelipase Market is valued at USD 1.94 billion in 2025 and is projected to grow at a CAGR of 4.2% to reach USD 2.81 billion by 2034. Pancrelipase Market The pancrelipase market revolves around...

November 2025 160 pages

Paracetamol Market Outlook 2026-2034: Market Share, and Growth Analysis By Form (Tablet, Capsules, Others)

US$ 3,950.00

The Paracetamol Market is valued at USD 10.48 billion in 2025 and is projected to grow at a CAGR of 5.2% to reach USD 16.54 billion by 2034. Paracetamol Market The global market for Paracetamol (also...

November 2025 160 pages

Proton Pump Inhibitors (PPIs) Market Outlook 2026-2034: Market Share, and Growth Analysis By Drug (OTC Drugs (Omeprazole, Lansoprazole, Esomeprazole), By Prescription Drugs (Rabeprazole, Dexlansoprazole, Pantoprazole))

US$ 3,950.00

The Proton Pump Inhibitors (PPIs) Market is valued at USD 3.89 billion in 2025 and is projected to grow at a CAGR of 4.9% to reach USD 5.98 billion by 2034. Proton Pump Inhibitors (PPIs) Market Proton...

November 2025 160 pages

Rosacea Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis By Disease (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), By Drug Class (Antibiotics, Immunosuppressants, Corticosteroids), By Route of Administration, By Treatment, By Distribution Channel

US$ 3,950.00

The Rosacea Therapeutics Market is valued at USD 2.12 billion in 2025 and is projected to grow at a CAGR of 6.4% to reach USD 3.71 billion by 2034. Rosacea Therapeutics Market The rosacea therapeutics...

November 2025 160 pages

Chronic Pruritus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

US$ 4,900.00

Chronic pruritus is a persistent and often severe form of itching that lasts for more than six weeks. It can be a symptom of various underlying medical conditions, including eczema, psoriasis, liver d...

November 2025 90 pages

Rosacea Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, End Users, and Region - Analysis and Forecast, 2025-2035

US$ 4,900.00

Rosacea is a chronic inflammatory skin condition that primarily affects the face, leading to persistent redness, visible blood vessels, and acne-like bumps. While it most commonly appears on the nose,...

October 2025 100 pages

Sarcopenia Market - A Global and Regional Analysis: Focus on Treatment Class, Route of Administration, Distribution Channel, and Region - Analysis and Forecast, 2025-2035

US$ 4,900.00

Sarcopenia is a progressive musculoskeletal disorder characterized by the loss of skeletal muscle mass, strength, and function, predominantly affecting older adults. It is clinically diagnosed based o...

October 2025 100 pages

5-Alpha Reductase Deficiency Market Outlook 2025-2034: Market Share, and Growth Analysis By Diagnosis (Chromosome Analysis, Gene Sequencing, Hormone Tests, Imaging Tests, Genetic Screening, Other Diagnosis), By Treatment (Surgery, Vaginoplasty, Feminizing Genitoplasty, Hormone Replacement Therapy, Other Treatments), By End-Users

US$ 3,950.00

The 5-Alpha Reductase Deficiency Market is valued at USD 1.8 billion in 2025 and is projected to grow at a CAGR of 7.7% to reach USD 3.5 billion by 2034.The 5-alpha reductase deficiency market is a ni...

October 2025 160 pages

Alexipharmic Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route Of Administration (Oral, Topical, Injectable, Other Routes Of Administration), By Application, By End Use

US$ 3,950.00

The Alexipharmic Drugs Market is valued at USD 3.7 billion in 2025 and is projected to grow at a CAGR of 5.4% to reach USD 5.9 billion by 2034.The Alexipharmic Drugs Market is a specialized sector wit...

October 2025 160 pages

Alpha Mannosidosis Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT)), By Indication (Type I, Type II, Type III), By End User

US$ 3,950.00

The Alpha Mannosidosis Market is valued at USD 16.2 billion in 2025 and is projected to grow at a CAGR of 20.3% to reach USD 85.4 billion by 2034.The Alpha Mannosidosis Market is a niche sector within...

October 2025 160 pages

Antibacterial Products Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Body Wash, Body Moisturizer, Hand Cream and Lotion, Hand Soaps, Hand Sanitizers, Facial Cleansers, Facial Mask ), By Form (Bar, Powder, Liquid ), By Distribution Channel

US$ 3,950.00

The Antibacterial Products Market is valued at USD 39.3 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 61.2 billion by 2034.The Antibacterial Products Market encompasses a wid...

October 2025 160 pages

Antidiarrhoeals Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Mucosal Protectants, Motility Modifying Drugs), By Application (Adults, Childrens), By Type

US$ 3,950.00

The Antidiarrhoeals Market is valued at USD 4.7 billion in 2025 and is projected to grow at a CAGR of 3.7% to reach USD 6.5 billion by 2034.The Antidotes Market focuses on the development and distribu...

October 2025 160 pages

Antidotes Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Chemical Antidotes, Physical Antidotes, Pharmacological Antidotes, Other Types), By Route Of Administration (Injectable, Oral, Capsules And Tablets, Syrup), By Application, By End-User

US$ 3,950.00

The Antidotes Market is valued at USD 2.9 billion in 2025 and is projected to grow at a CAGR of 10.8% to reach USD 7.3 billion by 2034.The Antidotes Market is a specialized segment within the pharmace...

October 2025 160 pages

Antiemetics And Antinauseants Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types), By Application, By End Users

US$ 3,950.00

The Antiemetics And Antinauseants Market is valued at USD 9.7 billion in 2025 and is projected to grow at a CAGR of 3.8% to reach USD 13.5 billion by 2034.The Antiemetics and Antinauseants Market focu...

October 2025 160 pages

Antifungals Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By Route of Administration (Oral, Parenteral, Topical), By End users

US$ 3,950.00

The Antifungals Market is valued at USD 23.7 billion in 2025 and is projected to grow at a CAGR of 10.5% to reach USD 58.2 billion by 2034.The Antifungals Market focuses on the development and distrib...

October 2025 160 pages

Antiobesity Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs), By Type (Prescription Drugs (Rx), OTC Drugs), By Medication

US$ 3,950.00

The Antiobesity Market is valued at USD 5.2 billion in 2025 and is projected to grow at a CAGR of 12.9% to reach USD 15.5 billion by 2034.The Antiobesity Market encompasses a broad range of products a...

October 2025 160 pages

Antispasmodics Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Dicyclomine Hydrochloride, Loperamide Hydrochloride, Other Drugs), By Indication (Irritable Bowel Syndrome, Stomach Cramps, Other Indications), By Route Of Administration, By Distribution Channel, By End-User

US$ 3,950.00

The Antispasmodics Drugs Market is valued at USD 12.8 billion in 2025 and is projected to grow at a CAGR of 10% to reach USD 30.2 billion by 2034.The Antispasmodics Drugs Market focuses on the develop...

October 2025 160 pages

Antivirals Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes), By Application

US$ 3,950.00

The Antivirals Market is valued at USD 93.8 billion in 2025 and is projected to grow at a CAGR of 9% to reach USD 204.1 billion by 2034.The Antivirals Market focuses on the development and distributio...

October 2025 160 pages

Arthritis Monoclonal Antibodies Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications), By End-Use

US$ 3,950.00

The Arthritis Monoclonal Antibodies Market is valued at USD 58.7 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 112.4 billion by 2034.The arthritis monoclonal antibodies marke...

October 2025 160 pages

Cephalosporin Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Branded, Generic), By Route Of Administration (Injection, Oral), By Application

US$ 3,950.00

The Cephalosporin Market is valued at USD 15.6 billion in 2025 and is projected to grow at a CAGR of 3.5% to reach USD 21.3 billion by 2034. The cephalosporin market has been a cornerstone of the anti...

October 2025 160 pages

Complicated Skin And Skin Structure Infections Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Linezolid, Other Active Ingredients), By Route of Administration (Oral, Topical, Parenteral), By End User

US$ 3,950.00

The Complicated Skin And Skin Structure Infections Drugs Market is valued at USD 9.1 billion in 2025 and is projected to grow at a CAGR of 12.2% to reach USD 25.7 billion by 2034.The complicated skin...

October 2025 160 pages

Constipation Laxative Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxative, Other Drugs), By Route Of Administration (Oral, Rectal), By Distribution Channel

US$ 3,950.00

The Constipation Laxative Market is valued at USD 8.8 billion in 2025 and is projected to grow at a CAGR of 6.2% to reach USD 15.1 billion by 2034.The constipation laxative market continues to grow as...

October 2025 160 pages

Glycopeptide Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication, By End-User

US$ 3,950.00

The Glycopeptide Antibiotics Market is valued at USD 4.7 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 9.7 billion by 2034. Glycopeptide Antibiotics Market Overview The glyco...

October 2025 160 pages

Proton Pump Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole, Other Types), By Disease Allocation (Ulcers, Gastroesophageal Reflux Disease, Other Disease Indications), By Application

US$ 3,950.00

The Proton Pump Inhibitors Market is valued at USD 4.1 billion in 2025 and is projected to grow at a CAGR of 4.6% to reach USD 6.1 billion by 2034. Proton Pump Inhibitors Market Overview The proton pu...

October 2025 160 pages

Psoriasis Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication, By Route Of Administration, By Distribution Channel

US$ 3,950.00

The Psoriasis Market is valued at USD 24.4 billion in 2025 and is projected to grow at a CAGR of 12.5% to reach USD 70.7 billion by 2034. Psoriasis Market Overview The psoriasis market encompasses a w...

October 2025 160 pages

Throat Lozenges Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Hard Candy Lozenges, Soft Lozenges, Compressed Lozenges), By Ingredient (Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey And Ginger, Lemon, Other Ingredients), By Distribution Channel, By Application

US$ 3,950.00

The Throat Lozenges Market is valued at USD 6.8 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 11 billion by 2034.The Throat Lozenges Market continues to be a staple within th...

October 2025 160 pages

Acne Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User

US$ 3,950.00

The Acne Drugs Market is valued at USD 7.7 billion in 2025 and is projected to grow at a CAGR of 3.9% to reach USD 10.9 billion by 2034.The acne drugs market is a dynamic sector focused on providing p...

October 2025 160 pages

Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration, By Drug Classification, By Mode Of Purchase

US$ 3,950.00

The Anti-Infective Drugs Market is valued at USD 161.4 billion in 2025 and is projected to grow at a CAGR of 6.1% to reach USD 274.1 billion by 2034.The Anti-Infective Drugs Market focuses on the deve...

October 2025 160 pages

Anti-Thyroid Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Thionamides (Inhibition of hormone synthesis), Iodides (Inhibition of hormone release)), By Route of Administration (Oral, Intravenous, Other Route of Administration), By Distribution Channel

US$ 3,950.00

The Anti-Thyroid Drugs Market is valued at USD 3.1 billion in 2025 and is projected to grow at a CAGR of 2.4% to reach USD 3.8 billion by 2034.The Anti-Thyroid Drugs Market centers on the production a...

October 2025 160 pages

Antiviral Combination Therapy Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Branded, Generic), By Drug Combination, By Route Of Administration, By Distribution Channel, By Indication,

US$ 3,950.00

The Antiviral Combination Therapy Market is valued at USD 51.6 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 98.8 billion by 2034.The Antiviral Combination Therapy Market foc...

October 2025 160 pages

Aspirin Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Prescription, OTC), By Route Of Administration (Oral, Rectal, Parenteral ), By Dosage Form, By Application, By End User

US$ 3,950.00

The Aspirin Market is valued at USD 3.3 billion in 2025 and is projected to grow at a CAGR of 5.3% to reach USD 5.3 billion by 2034. Aspirin Market The aspirin market has remained a cornerstone of the...

October 2025 160 pages

Barrett'S Esophagus Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types), By Treatment (Medication, Endoscopic Therapy, Surgery, Other Treatments), By Route Of Administration, By Distribution Channel

US$ 3,950.00

The Barrett'S Esophagus Market is valued at USD 8 billion in 2025 and is projected to grow at a CAGR of 5.1% to reach USD 12.5 billion by 2034. Barrett’s Esophagus Market Overview The Barrett’s esopha...

October 2025 160 pages

Carbapenem-Based Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Meropenem, Imipenem, Doripenem, Tebipenem, Other Types), By Indication, By Distribution Channel

US$ 3,950.00

The Carbapenem-Based Antibiotics Market is valued at USD 5.7 billion in 2025 and is projected to grow at a CAGR of 4.4% to reach USD 8.4 billion by 2034. Carbapenem-Based Antibiotics Market The carbap...

October 2025 160 pages

Consumer Healthcare Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (OTC Pharmaceuticals, Dietary Supplements ), By Application (Retail, Online, Hospitals)

US$ 3,950.00

The Consumer Healthcare Market is valued at USD 696.1 billion in 2025 and is projected to grow at a CAGR of 19.9% to reach USD 3562.2 billion by 2034.The Consumer Healthcare market is a dynamic and ra...

October 2025 160 pages

Cough And Cold Preparations Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drug Types), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Other Dosage Types), By Distribution Channel

US$ 3,950.00

The Cough And Cold Preparations Market is valued at USD 72.9 billion in 2025 and is projected to grow at a CAGR of 5.4% to reach USD 116.5 billion by 2034.The global cough and cold preparations market...

October 2025 160 pages

Crohn'S Disease (Cd) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Route of Administration (Oral, Injectable), By Distribution Channel

US$ 3,950.00

The Crohn'S Disease (Cd) Treatment Market is valued at USD 10.8 billion in 2025 and is projected to grow at a CAGR of 5.6% to reach USD 17.6 billion by 2034.The Crohn’s Disease (CD) treatment market h...

October 2025 160 pages

Crohn'S Disease Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application

US$ 3,950.00

The Crohn'S Disease Treatment Market is valued at USD 11.8 billion in 2025 and is projected to grow at a CAGR of 6.9% to reach USD 21.4 billion by 2034.The Crohn’s Disease treatment market continues t...

October 2025 160 pages

Denosumab Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Classification (Prolia, Xgeva, Others), By Type (60 mg, 120 mg), By End-Users

US$ 3,950.00

The Denosumab Market is valued at USD 4.3 billion in 2025 and is projected to grow at a CAGR of 15.2% to reach USD 15.3 billion by 2034.The Denosumab Market focuses on the pharmaceutical drug denosuma...

October 2025 160 pages

Filters

Search

Publishers

12
2
8
18
24
6
22
2
82
138
7
18
7
3
9
2
2
25

Regions

16
1
3
1
1
1
1
1
357
2
1
1
1

Price

Date

Pages

Offers